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INTRODUCTION
Haemorrhagic shock is a life-threatening condition resulting
from blood loss, and the cardiovascular response to haemorrhage
can be divided into three phases. The first one is characterized by
an increase of the sympathetic nervous system activity, with
tachycardia and a rise in the peripheral resistance. In the second
phase, the activation of unmyelinated vagal afferents from the
left ventricle initiates a decrease in the sympathetic activity, with
a fall in the peripheral resistance and bradycardia. Finally,
continuous blood loss leads to a further decrease in blood
pressure accompanied by tachycardia (1).
Experimental studies demonstrate an influence of many
neuronal systems, including opioidergic (2), melanocortinergic (3),
serotonergic (4), cholinergic (5) and histaminergic system (6), on
the sympathoinhibitory phase of regulation in critical
hypovolaemia. Histaminergic neurons are concentrated at the
tuberomammillary nuclei of the hypothalamus and send axons to
many parts of the central nervous system influencing circadian
rhythms, thermoregulation, learning and memory, nociceptive
responses, feeding behaviour, hypothalamic and pituitary hormone
secretion and cardiorespiratory control (7). In normotension,
histamine acting as a neurotransmitter induces an increase in mean
arterial pressure (MAP) with bradycardia in conscious and
tachycardia in anaesthetised animals (8). Interestingly, in critical
haemorrhagic hypotension, histamine evokes a long-lasting and a
few fold higher pressor effect in comparison to normotensive rats,
with an improvement in survival (6). We demonstrated an
involvement of the sympathetic nervous system, the renin-
angiotensin system, as well as of arginine vasopressin (AVP) and
proopiomelanocortin (POMC)-derived peptides in histamine-
induced resuscitating action (9). Haemodynamic mechanisms
responsible include the mobilisation of blood from venous
reservoirs leading to a partial normalisation of peripheral blood
flows and blood gas and acid-base parameters (10-11).
Leptin is a peptide hormone secreted by adipocytes which
decreases energy consumption by reducing appetite and
increasing energy expenditure, possibly via increased
thermogenesis (12). The former effect is associated with centrally-
mediated activation of the sympathetic nervous system, which is
not restricted to the adipose tissue, and concerns also the
cardiovascular system (13). Experimental studies demonstrate that
after administration into the third cerebral ventricle or lateral
ventricle (icv.), the peptide evokes a long-lasting increase in MAP
in normotensive conscious (13) and anaesthetised rats (14).
Moreover, in a rat model of irreversible haemorrhagic shock,
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Leptin, acting centrally as a neuromodulator, induces the activation of the sympathetic nervous system, which may lead
to a pressor action in normotensive animals. In haemorrhagic shock, leptin administered intracerebroventricularly (icv.)
evokes the resuscitating effect, with long-lasting rises in mean arterial pressure (MAP) and heart rate (HR), subsequent
increase in peripheral blood flows, and a 100% survival at 2 h. Since leptin is able to activate histaminergic neurons,
and centrally acting histamine also induces the resuscitating effect with the activation of the sympathetic nervous
system, in the present study, we investigated an involvement of the histaminergic system in leptin-evoked cardiovascular
effects in haemorrhagic shock. The model of irreversible haemorrhagic shock, with MAP decreased to and stabilised at
20 – 25 mmHg, has been used. Leptin (20 µg) given icv. at 5 min of critical hypotension evoked 181.5% increase in
extracellular hypothalamic histamine concentration during the first 10 min after injection. Rises in MAP, HR and renal,
mesenteric and hindquarters blood flows induced by leptin were inhibited by icv. pre-treatment with histamine H1
receptor antagonist chlorpheniramine (50 nmol). In contrast, there was no effect of H2, H3 and H4 receptor antagonists
ranitidine (25 nmol), VUF 5681 (25 nmol) and JNJ 10191584 (25 nmol), respectively. In conclusion, the histaminergic
system is involved in centrally-acting leptin-induced resuscitating effect in haemorrhagic shock in rats.
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leptin induces a long-lasting pressor effect with the increase in
survival, and the mechanism includes the activation of the
sympathetic nervous system (15). Since leptin, acting as a
neuromodulator, is able to enhance the activity of histaminergic
neurons (16), and both histamine and leptin have common
mechanism involved in the resuscitating action, the purpose of the
study was to examine the involvement of the histaminergic system
in leptin-mediated cardiovascular effects in haemorrhagic shock.
MATERIAL AND METHODS
Animals
All procedures were performed in accordance to the EU
directives and reviewed by the local Ethics Committees
(Katowice, Poland and Bursa, Turkey; notifications No 23/2010,
09/2011, 28/2012, 29/2012, 84/2014 and 2009-11/03).
Studies were performed in male Wistar rats weighing 230 –
284 g (5 – 6 months old). The animals were housed in individual
cages in the animal colony, under standard, controlled conditions
(temperature 20 – 22°C, humidity 60 – 70%, 12 h light/dark
cycle) and provided with food and water ad libitum.
Surgical preparation
After induction of general anaesthesia with
ketamine/xylazine (100 mg/kg + 10 mg/kg intraperitoneally,
supplemented if required), rats were implanted with catheters
filled with heparinised saline (300 IU/ml) in the right carotid
artery and the right jugular vein. MAP and heart rate (HR) were
measured using TAM-A transducer amplifier module and ECGA
amplifier (Hugo Sachs Elektronik, Germany), respectively. The
electromagnetic perivascular probes (type 1RB and 2.5SB, Hugo
Sachs Elektronik, Germany) were implanted around the right
renal and superior mesenteric arteries to monitor renal (RBF)
and mesenteric (MBF) blood flow and around the distal
abdominal aorta, below the ileocaecal artery, to monitor
perfusion of the hindquarters (HBF) using TTFM transit time
flowmeter module (Transonic Systems Inc., USA). All
measurements of blood flow were started after a 30 min
adaptation period to avoid influences of probe implantation.
Regional vascular resistances were calculated by dividing MAP
(mmHg) by regional blood flows (ml/min).
For i.c.v. treatment, rats were prepared 5 – 7 days before the
experiment by stereotaxic implantation, under ketamine/xylazine
anaesthesia, of polyethylene cannulae into the right brain lateral
ventricle as previously described (6). All icv. injections were
made in the volume of 5.0 µl. Correctness of injections was
verified as previously described (6).
Experimental protocol
Severe haemorrhagic shock, according to the method by
Guarini et al. (3), was produced by intermittent blood
withdrawal from the catheter inserted into the right jugular vein
over a period of 15 – 25 min, until MAP decreased to and
stabilised at 20 – 25 mmHg.
Immediately after induction of critical MAP, the animals
were pre-treated icv. with the histamine H1-H4 receptor
antagonists chlorpheniramine (50 nmol), ranitidine (25 nmol),
VUF 5681 (25 nmol) and JNJ 10191584 (25 nmol), respectively,
or saline. Five min later, rats were injected icv. with leptin (20 µg)
or saline. Doses of leptin and histamine H1-H2 receptor ligands
were taken from the literature (6, 15, 17). VUF 5681 and JNJ
10191584 were administered at an equimolar dose to previously
used thioperamide, H3 receptor inverse agonist/H4 antagonist
(18). Animals were continuously monitored for 2 hours after
treatment, or until death, if it occurred earlier. Body temperature
was monitored by a rectal thermometer and maintained at 37 ±
0.5°C using heating lamps throughout experiment. All the
experiments were performed between 8.00 and 14.00.
According to recommendations of the Local Ethics
Committee in Katowice, to avoid the duplication of experiments
performed at our laboratory with the same rat strain, using the
same experimental protocol and with the same H1 and H2
receptor antagonists (6, 17), we did not repeat experiments in the
control saline icv.-treated groups and cited and discussed
previously published results, especially that the mortality at 2 h
in these groups was 100%.
Microdialysis study
Handmade microdialysis probes (by Burcin Altinbas) were
used. Anaesthetised and catheterised rats were placed in a
stereotaxic frame. The skull was exposed and drilled over the
posterior hypothalamus (coordinates: 3.6 mm posterior to
bregma, 0.5 mm lateral (right) to the midline and 9.0 mm vertical
to the skull). Probes (molecular weight cut-off dialysis
membrane was 18.000 Da and length was 2.0 mm) were
implanted and then fixed with acrylic cement to the skull.
At the end of the probe placement, the arterial catheter was
connected to a transducer for MAP monitoring, and the
microdialysis probe was attached to perfusion pump. The dialysis
probe was perfused with artificial cerebrospinal fluid (pH 7.4) of
the following composition: 120 mmol/l NaCl, 1.3 mmol/l CaCl2,
1.2 mol/l MgSO4, 1.2 mmol/l NaH2PO4, 3.5 mmol/l KCl, 25
mmol/l NaHCO3 and 10 mmol/l glucose. The perfusion rate was
2 µl/min. The dialysis probe was perfused for the first 60 min of
the stabilisation period and samples were collected at 10 min
intervals. After this period, one more sample was collected before
haemorrhage and this sample was measured as basal histamine
level. Collection of microdialysis samples was continued 70 min
after the start of bleeding. At the end of the experiments, the
animals were decapitated, and for the determination of
microdialysis probe location, brains were fixed in 4%
paraformaldehyde, and 50 micrometer-thick vibratom sections
were collected. Sections were stained with haematoxylin-eosin
for 15 min. Excess stain was washed off in distilled water and the
sections were dehydrated by rinses through graduated ethanol
series. Following the cleaning step in xylene, the sections were
coverslipped using dispersive pipet extraction. Probe localization
was determined and representative pictures (Fig. 1) were taken
using an Olympus BX-50 microscope adapted with a CCD digital
camera.
High-performance liquid chromatography (HLPC)
measurement of histamine levels
Extracellular histamine levels at the posterior hypothalamus
were measured by HPLC (Jasco PU-980 Intelligent HPLC
pump; Kipp & Zonen printer) and UV detection (Jasco UV-975
Intelligent UV-VIS detector) at a wavelength of 220 nm using a
C18 column (Hypersil C18; 5 µm; 25 cm; 4.6 mm ID) with an
isocratic system (0.04 mol/l KH2PO4, 0.015 mol/l sodium-1-
heptasulfonate and 25% acetonitrile, pH 3.1). Flow rate was 2.0
ml/min. Chromatograms were completed within 10 min.
Drugs
The following drugs were used: leptin (rat, recombinant)
(Sigma-Aldrich, USA), chlorpheniramine maleate, ranitidine
hydrochloride (Research Biochemicals Incorporated, USA), JNJ
10191584, VUF 5681 (Tocris Bioscience, UK), ketamine
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hydrochloride, xylazine (Biowet Sp. z o. o., Poland), heparin
(Polfa, Poland). All drug solutions were prepared freshly on the
day of the experiment.
Statistical analysis
All values are given as means ± standard deviation, with P <
0.05 considered as the level of significance. The Fisher’s exact
test was used to examine statistical differences in survival
percentage. Histamine levels were compared by Kruskal-Wallis
test, whereas statistical evaluation of the other results was
performed using analysis of variance (ANOVA) and the post-
ANOVA test of Student-Newman-Keuls.
RESULTS
The initial pre-bleeding values of MAP, pulse pressure (PP),
HR and peripheral blood flows in all groups did not reveal
significant differences.
The total bleeding volume necessary for the induction of
critical MAP in all animals was 2.43 ± 0.35 ml/100 g body
weight. In the control saline icv. injected group, bleeding from
MAP 85.3 ± 6.56 mmHg to 23.11 ± 1.12 mmHg was associated
with a decrease in PP from 43.76 ± 5.85 mmHg 15.32 ± 3.7
mmHg and HR from 324 ± 18 beats/min to 210 ± 23 beats/min
(Fig. 2). Furthermore, haemorrhage led to a decrease in RBF
from 4.97 ± 0.78 ml/min to 0.87 ± 0.22 ml/min, HBF from 10.84
± 1.48 ml/min to 2.35 ± 0.65 ml/min and MBF from 6.75 ± 1.29
ml/min to 1.29 ± 0.12 ml/min (Fig. 3). Initial renal (RVR),
hindquarters (HVR) and mesenteric vascular resistance (MVR)
in the control saline-injected group were: 17.35 ± 2.0
mmHg/ml/min, 7.95 ± 1.33 mmHg/ml/min and 12.2 ± 1.64
mmHg/ml/min, respectively (Fig. 4). After shock induction,
vascular resistances were increased to 27.5 ± 3.6 mmHg
min/ml/ml, 11.0 ± 3.0 mmHg/ml/min and 22.8 ± 4.9
mmHg/ml/min, respectively (Fig. 4).
Influence of histamine receptor ligands on haemodynamic
effects of leptin in haemorrhage-shocked rats
Leptin administered to haemorrhage-shocked rats induced
an increase in MAP, PP and HR (Fig. 2), which were
accompanied by a rise in peripheral blood flows (Fig. 3). The
effects started within 10 – 15 min after leptin injection, were
long-lasting and associated with 100% survival rate at 2 h (P <
0.05 versus control saline-treated animals, Fisher’s exact test).
Since the bleeding termination to the end of the observation
period peripheral vascular resistances were increased (Fig. 4). In
the saline-pre-treated group, 20 min after leptin injection RVR,
HVR and MVR were still increased by 56.4%, 35.9% and
115.3%, respectively, in comparison with the pre-bleeding
values (Fig. 4).
In the saline-treated control group, there we no increases in
MAP, PP, HR (Fig. 2) and peripheral blood flows (Fig. 3), and
all animals died within 30 min.
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Fig. 1. Photomicrograph of a typical
placement of microdialysis probe in
the posterior hypothalamus; the arrow
indicates the tip of the microdialysis
probe; 3V - third ventricle;
haematoxylin-eosin staining.
Chlorpheniramine inhibited MAP, PP and regional
haemodynamic effects of leptin (Figs. 2-4), however, without
influence on HR and survival rate at 2 h. The antagonist given
alone, as we showed previously (6), had no influence on
haemodynamic parameters in the icv. saline-treated control group.
On the other hand, H2, H3 and H4 receptor blockers
ranitidine, VUF 5681 and JNJ 10191584 did not influence
measured cardiovascular parameters (Figs. 2-3) and calculated
peripheral vascular resistances (Fig. 4) in leptin-treated group.
The antagonists given alone in the control groups, as we reported
previously with ranitidine (17) and studied here with VUF 5681
and JNJ 10191584 (data not shown), had no influence on
measured haemodynamic parameters and calculated peripheral
vascular resistances.
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Fig. 2. Influence of icv. pre-treatment with chlorpheniramine (50
nmol), ranitidine (25 nmol), VUF 5681 (25 nmol), JNJ
10191584 (25 nmol) and saline (5 µl) on MAP (A), PP (B) and
HR (C) after leptin (20 µg, icv.) administration in rats subjected
to critical haemorrhagic hypotension. Means ± S.D., 6 animals
per group. In all leptin-treated groups, since 10 min (MAP, PP)
and 25 min (HR) till the death of control animals P < 0.05 versus
the saline-treated control group; *P < 0.05 versus the saline-pre-
treated leptin-injected group; previous (6, 17) and present
studies with histamine receptor ligands (data not shown) did not
evoke MAP, PP and HR changes after their administration in the
control groups.
Fig. 3. Influence of icv. pre-treatment with chlorpheniramine (50
nmol), ranitidine (25 nmol), VUF 5681 (25 nmol), JNJ 10191584
(25 nmol) and saline (5 µl) on RBF (A), HBF (B) and MBF
changes (C) after leptin (20 µg, icv.) administration in rats
subjected to critical haemorrhagic hypotension. Means ± S.D., 6
animals per group. Pre-bleeding values of RBF, HBF and MBF in
the control group were: 4.97 ± 0.78 ml/min, 10.84 ± 1.48 ml/min
and 6.75 ± 1.29 ml/min, respectively. In all leptin-treated groups,
since 10 min (HBF), 15 min (MBF) and 20 min (RBF) till the
death of control animals P < 0.05 versus the saline-treated control
group; *P < 0.05 versus the saline-pre-treated leptin-injected
group; previous (6, 17) and present studies with histamine
receptor ligands (data not shown) did not reveal peripheral blood
flow changes after their administration in the control groups.
Influence of leptin on histamine release in the posterior
hypothalamus in critically hypotensive rats
In vivo microdialysis studies showed that the basal
extracellular histamine concentrations at the posterior
hypothalamus in control and leptin-treated groups were 0.14 ±
0.03 pmol/10 min and 0.133 ± 0.08 pmol/10 min, respectively
(Fig. 5). Induction of critical haemorrhagic hypotension did not
significantly influence histamine concentrations (Fig. 5).
Intracerebroventricular administration of leptin (20 µg)
evoked 181.5% increase in extracellular histamine levels at the
posterior hypothalamus during the first 10 min after injection
(Fig. 5). On the contrary, in the control group there were no
significant changes in the posterior hypothalamic histamine
levels within 10 min after saline treatment (Fig. 5).
DISCUSSION
Centrally acting leptin influences cardiovascular regulation
both in normotension (13, 19) and critical haemorrhagic
hypotension (15). Present results extend previous studies and
show for the first time the influence of leptin on the activity of
histaminergic neurones in critical hypovolaemia. However, the
main novel finding in this study is the direct demonstration of
the involvement of the histaminergic system in leptin-mediated
resuscitating effect in haemorrhage-shocked rats.
Due to a low permeability of the blood-brain barrier,
similarly to previous studies (15), we administered leptin
centrally, although the influence of circulating leptin on the
central cardiovascular regulation in haemorrhagic shock cannot
be excluded, since i) in focal and global cerebral
hypoxia/traumatic brain injury the blood-brain permeability
increases (20), ii) the effect is potentiated during oxidative stress
(21) which characterises the reperfusion phase of haemorrhagic
shock resuscitation and iii) peripherally administered leptin
induces neuroprotective effects on focal cerebral
ischemia/reperfusion injury (22).
As we confirmed here, leptin given at a dose 20 µg icv. to
rats subjected to critical haemorrhagic hypotension induces a
long-lasting and significantly higher increase in MAP, relative to
normotensive animals (15) with a reversal of bradycardia and
improvement of the survival rate at 2 h, which is considered as a
long-lasting survival. The action of leptin is accompanied by the
rise in RBF, MBF and HBF, as demonstrated since 10 min after
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Fig. 4. RVR (A), HVR (B) and MVR (C) before and after
bleeding termination, and 20 min after icv. injection with
leptin (L, 20 µg) in groups pre-treated with chlorpheniramine
(CHL, 50 nmol), ranitidine (RAN, 25 nmol), VUF 5681 (VUF,
25 nmol), JNJ 10191584 (JNJ, 25 nmol), and in the control
saline-injected (S) group. Means ± S.D., 6 animals per group.
*P < 0.05 versus pre-bleeding value; #P < 0.05 versus
corresponding value in saline-pre-treated leptin injected
group.
 
Fig. 5. Hypothalamic extracellular
histamine concentrations before
bleeding, 10 and 20 min after the start
of bleeding and 10 – 40 min after icv.
leptin (20 µg) or saline injections.
Means ± S.D., 4 animals per group.
*P < 0.05 versus saline-treated group.
There are no results of histamine
levels in the control group at 20, 30
and 40 min of critical hypovolaemia,
because all animals died before the
collections.
treatment (15). We hypothesized that the haemodynamic
mechanism responsible for shock reversal is related to the
increase in the circulating blood volume, as a consequence of
blood mobilisation from venous reservoirs, that in turn leads to
the increase in peripheral blood flows. This hypothesis is
supported by the finding of a long-lasting vasoconstriction,
especially in the mesenteric region (15). The differences among
RVR, MVR and HVR can be explained by the specificity of the
sympathetic innervations of these vascular beds, as well as the
different vascular density of receptors for endogenous
vasoconstrictors. Similar differences in regional peripheral
blood flows and vascular resistances were described earlier in
studies regarding cardiovascular effects of the histaminergic
system activation (9) and the treatment with AVP (23) in
haemorrhagic shock.
Our data may suggest a potential direction of a new
adjunctive pharmacological intervention in haemorrhagic shock,
however, it is difficult to assess their clinical significance,
especially that i) leptin was given centrally, ii) we used a model
of isolated haemorrhagic shock, whereas in humans it is often
accompanied by polytrauma and iii) anaesthesia, volume
replacement and other standard therapeutics used to treat
haemorrhagic shock might interfere with leptin action in
hypovolaemia. Experimental studies demonstrate the influence
of anaesthesia on cardiovascular regulation in hypovolaemia i.e.
the shortening of the sympathoexcitatory phase (24). In the
present studies, all injections of leptin were performed in the
second, sympathoinhibitory phase, however, we cannot exclude
a possible influence of anaesthesia on leptin-mediated
cardiovascular effects, although both in conscious (13) and
anaesthetized normotensive rats (14) centrally acting leptin
induces a pressor effect.
According to the model used, the animals were monitored
for 2 hours and in that time leptin evoked an improvement in
measured cardiovascular parameters and survival rate. However,
since the main mechanism of action is the activation of the
sympathetic nervous system (15) associated with an increase in
energy expenditure, further studies are needed to fully assess a
long-lasting metabolic effects of leptin action.
Central neuronal pathways involved in leptin-mediated
resuscitating action in haemorrhagic shock are not clear.
According to the published literature, we suggest indirect
mechanisms since leptin is able to stimulate neurons located in
the arcuate nucleus and projecting to the paraventricular nucleus
(PVN) of the hypothalamus, where they release α-melanocyte
stimulating hormone (α-MSH) (25). On the other hand, in vivo
electrophysiological studies demonstrate that leptin activates the
sympathetic nervous system by stimulating α-MSH release in
PVN (19). Since α-MSH and other POMC-derived peptides have
protective effects due to the activation of the cholinergic anti-
inflammatory pathway in haemorrhagic shock, multiple organ
dysfunction syndrome and other critical conditions (26-28), we
hypothesize that the leptin-induced resuscitating effect may be
mediated via POMC-derived peptides; further, the central
melanocortinergic system favourably influences the sympathetic
tone and, this way, MAP values, as results of in vivo (29) and in
vitro (30) studies demonstrate. In addition, findings by Fekete
and Liposits (31) show that the α-MSH-containing neurons of the
arcuate nucleus directly innervate histaminergic neurons in the
tuberomammillary nucleus and therefore, may be involved in the
mediation of leptin action on this neuronal system. Indeed, in vivo
microdialysis studies demonstrate an increase in histamine
release at the anterior hypothalamus after intraperitoneal
administration of leptin in normotensive anaesthetised rats (32)
and mice (16). In the present study, we demonstrate for the first
time leptin-induced increase in hypothalamic histamine release in
haemorrhage-shocked animals.
To further determine the role of the histaminergic system in
the central leptin-induced resuscitating action, we used
histamine receptor ligands. Haemodynamic results show that H1
receptors are involved in leptin-mediated resuscitating effect in
haemorrhagic shock. These data are in line with the previous
studies in which we demonstrated the role of H1 receptor in the
resuscitating effect of centrally acting endogenous and
exogenous histamine (9). H1 receptors are involved also in the
mediation of the pressor effect of centrally acting cytidine 5’-
diphosphocholine (17) and the agonist of 5-HT1A receptor 8-OH-
DPAT (33). Moreover, pre-treatment with chlorpheniramine
decreases leptin-induced increase in MAP and iliac
vasoconstriction (15), and the H1 receptor antagonist
diphenhydramine blocks leptin-evoked increases in MAP and
the renal sympathetic nerve activity in normotensive rats (33).
Similarly to our previous studies concerning the role of the
histaminergic system in the central cardiovascular regulation in
shock (18), here we did not find any influence of central H2, H3 and
H4 receptor blockade on leptin-mediated effects. Presynaptic H3
receptors mediate autoinhibition of histamine release from the
histaminergic neurons as well as regulation of the synthesis/release
of other neurotransmitters (7). Tanida et al. (34) demonstrated that
H3/4 receptor antagonist/inverse agonist thioperamide inhibits
changes in the renal sympathetic nerve activity and MAP evoked
by low doses of histamine in normotensive rats. In contrast, VUF
5681, a silent/neutral H3 receptor antagonist did not affect
measured cardiovascular parameters in shock. We hypothesize that
the difference can be explained by the pharmacological properties
of the used H3 ligands.
Despite a single report on the functional expression of
histamine H4 receptors in the mammalian brain (35), we showed
no influence of the H4 receptor antagonist JNJ 10191584 on the
central cardiovascular regulation in leptin-injected and saline-
treated animals. These results are in agreement with our previous
studies in which thioperamide did not affect the action of
cholinergic (17) and serotonergic ligands (18) in haemorrhagic
shock.
Although we demonstrated the involvement of the
histaminergic system in leptin-mediated cardiovascular effects
in shock, there are limitations of our study. In addition to the
melanocortinergic and histaminergic systems, centrally acting
leptin is able to influence the activity of other neuronal
pathways, and their role in the observed resuscitating effect
cannot be excluded. The study by Garcia et al. (36) showed a
leptin-mediated increase in the central thyrotropin-releasing
hormone (TRH) synthesis and release, and TRH evokes an
increase in the sympathetic tone in normotensive animals (37)
and induces a resuscitating effect in experimental haemorrhagic
shock (38). Moreover, leptin is involved in AVP synthesis and
secretion (32), and AVP belongs to essential compensatory
pathways in haemorrhagic shock (39). Finally, we did not study
particular neuronal pathways activated by leptin. We injected it
icv., similarly as it was performed in the studies concerning the
function of other poorly penetrating the blood-brain barrier
neurotransmitters/neuromodulators (40-42).
In conclusion, the results of our studies directly demonstrate
for the first time the involvement of the histaminergic system in
centrally-acting leptin-induced resuscitating effect in
haemorrhagic shock in rats.
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